TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.58 CNY | +0.70% |
|
+0.23% | -4.05% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 2.04B 282M 22.15B | Sales 2023 | 2.05B 282M 22.15B | Capitalization | 11.92B 1.65B 129B |
|---|---|---|---|---|---|
| Net income 2022 | 472M 65.15M 5.11B | Net income 2023 | 581M 80.2M 6.29B | EV / Sales 2022 | 5.65 x |
| Net cash position 2022 | 505M 69.68M 5.47B | Net cash position 2023 | 831M 115M 9B | EV / Sales 2023 | 5.42 x |
| P/E ratio 2022 |
25.7
x | P/E ratio 2023 |
20.5
x | Employees | 3,091 |
| Yield 2022 |
1.71% | Yield 2023 |
2.13% | Free-Float | 10.61% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.70% | ||
| 1 week | +0.23% | ||
| 1 month | -2.84% | ||
| 3 months | +1.79% | ||
| 6 months | -9.71% | ||
| Current year | -4.05% |
1 week
21.30
21.88
1 month
21.3023.26
Current year
16.2723.26
1 year
16.2726.48
3 years
16.2735.50
5 years
16.2745.23
10 years
14.6450.30
| Managers | Title | Age | Since |
|---|---|---|---|
Xiao Mei Yao
DFI | Director of Finance/CFO | 54 | 28/08/18 |
Kai Lie Liu
PSD | President | 60 | 23/01/09 |
Ju Fang Lei
CHM | Chairman | 71 | 07/10/07 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ju Fang Lei
CHM | Chairman | 71 | 07/10/07 |
Kai Lie Liu
PSD | President | 60 | 23/01/09 |
Ou Zhu Suo Lang
BRD | Director/Board Member | 59 | 09/02/14 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +3.86% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/05/24 | 21.58 | +0.70% | 721,377 |
| 30/05/24 | 21.43 | -0.46% | 679,300 |
| 29/05/24 | 21.53 | -0.37% | 623,100 |
| 28/05/24 | 21.61 | -0.92% | 795,018 |
| 27/05/24 | 21.81 | +1.30% | 825,653 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotes
Tibet Cheezheng Tibetan Medicine Co., Ltd is a China-based company, principally engaged in the research, development, manufacture and distribution of Tibetan medicines. The Company primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The Company's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
22/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -4.05% | 1.58B | |
| +37.29% | 6.02B | |
| -21.28% | 4.19B | |
| +4.52% | 3.25B | |
| -18.16% | 2.87B | |
| -7.70% | 2.37B | |
| +41.50% | 1.89B | |
| -15.56% | 1.54B | |
| -14.62% | 1.5B | |
| +40.06% | 1.45B |
- Stock Market
- Equities
- 002287 Stock